Encyclopedia of Cancer

Living Edition
| Editors: Manfred Schwab

Breast Cancer Stem Cells

  • Pranela Rameshwar
  • Shyam Patel
Living reference work entry
DOI: https://doi.org/10.1007/978-3-642-27841-9_6628-3



Breast cancer stem cells are self-renewing cells that form new tumor cells. They represent a small fraction of cells that are resistant to chemotherapy and radiation therapy. Chemotherapeutic agents with some effect on breast cancer stem cells include 5-fluorouracil, platinum-based agents (platinum complexes), taxol, and doxorubicin. The frequency of tumor stem cells varies, depending on tumor type. However, <5 % of tumor cells may exhibit stem-like phenotype with enhanced tumorigenicity as compared with the molecularly heterogeneous population without stem-like property.


Origins of the Breast Cancer Stem Cells

Tumors of many solid organs contain a population of cells with stem-like phenotype. Much evidence has accumulated on breast cancer stem cells, including expression of stem cell markersin heterogeneous populations of breast cancer cells. Nestin, an...


Breast Cancer Disseminate Tumor Cell Breast Cancer Stem Cell ALDH1 Expression Endogenous Stem Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.


  1. Balicki D (2007) Moving forward in human mammary stem cell biology and breast cancer prognostication using ALDH1. Cell Stem Cell 1:485–487PubMedCrossRefGoogle Scholar
  2. Corcoran KE, Trzaska KA, Fernandes H, Bryan M, Taborga M, Srinivas V, Packman K, Patel PS, Rameshwar P (2008) Mesenchymal stem cells in early entry of breast cancer into bone marrow. Plos ONE 3:e2563PubMedPubMedCentralCrossRefGoogle Scholar
  3. Lu X, Kang Y (2007) Organotropism of breast cancer metastasis. J Mammary Gland Biol Neoplasia 12:153–162PubMedCrossRefGoogle Scholar
  4. Pantel K, Alix-Panabières C, Riethdorf S (2009) Cancer micrometastases. Nat Rev Clin Oncol 6:339–351PubMedCrossRefGoogle Scholar
  5. Tanei T, Morimoto K, Shimazu K, Kim SJ, Tanji Y, Taguchi T, Tamaki Y, Noguchi S (2009) Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers. Clin Cancer Res 15:4234–4241PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  1. 1.Medicine-Hematology/OncologyRutgers, New Jersey Medical SchoolNewarkUSA
  2. 2.Standford UniversityPalo AltoUSA